Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves’ ophthalmopathy: a review

References

• WiersingaWMBartalenaLEpidemiology and prevention of Graves’ ophthalmopathyThyroid20021285586012487767
   PubMed Web of Science ®Google Scholar
• TjiangHLahootiHMcCorquodaleTParmarKRWallJREye and eyelid abnormalities are common in patients with Hashimoto’s thyroiditisThyroid20102028729020146657
   PubMed Web of Science ®Google Scholar
• WallJThyroid function: news and views: pathogenesis of Graves’ ophthalmopathy – a role for TSH-R?Nat Rev Endocrinol20143725625824663219
   PubMed Web of Science ®Google Scholar
• GirgisCMChampionBLWallJRGirgisCChampionBWallJCurrent concepts of Graves’ disease: a reviewTher Adv Endocrinol Metab2012213514423148179
   PubMedGoogle Scholar
• WeetmanAPGraves’ diseaseN Engl J Med20003431236124811071676
   PubMed Web of Science ®Google Scholar
• EcksteinAKPlichtMLaxHThyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the diseaseJ Clin Endocrinol Metab2006913464347016835285
   PubMed Web of Science ®Google Scholar
• PaschkeRVassartGLudgateMCurrent evidence for and against the TSH receptor being the common antigen in Graves’ disease and thyroid associated ophthalmopathyClin Endocrinol (Oxf)1995425655697634495
   PubMed Web of Science ®Google Scholar
• McCorquodaleTLahootiHGopinathBWallJRLong term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity – heterogeneity of autoimmune ophthalmopathyClin Ophthalmol201261922259229
   PubMedGoogle Scholar
• LahootiHHoutzJATranYCTSH receptor antibodies as measured in a thyroid stimulating immunoglobulin (TSI) reporter bioassay are not detected in patients with euthyroid Graves’ diseaseAustin J Clin Ophthalmol2014117
   Google Scholar
• GirgisCMChampionBLWallJRPsychological stress and soft-tissue manifestations of Graves’ disease: a potential link?AACE Clin Case Rep2015
   Google Scholar
• BartleyGBFatourechiVKadrmasEFClinical features of Graves’ ophthalmopathy in an incidence cohortAm J Ophthalmol19961212842908597271
   PubMed Web of Science ®Google Scholar
• KonishiJHermanMNKrissJPBinding of thyroglobulin and thyroglobulin-anti thyroglobulin complex to extraocular muscle membraneEndocrinology1974954344464136562
   PubMed Web of Science ®Google Scholar
• McDougallIRKrissJPNew thoughts about the cause and treatment of the severe ocular manifestations of Graves’ diseaseScot Med J1974191651694601348
   PubMed Web of Science ®Google Scholar
• Feldt-RasmussenUKempABechKMadsenANDateJSerum thyroglobulin, its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmosActa Endocrinol (Coph)198196192198
   PubMedGoogle Scholar
• KurokiTRufTWhelanLMillerAWallJRAntithyroglobulin monoclonal and autoantibodies cross-reactivity on orbital connective tissue antigen. A possible mechanism for the association of ophthalmopathy with autoimmune thyroid disordersClin Exp Immunol198569931936
   Google Scholar
• KodamaKSikorskaHBaylyRBandy-DafoePWallJUse of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathyJ Clin Endocrinol Metab19745967736327760
   PubMed Web of Science ®Google Scholar
• GohSYHoSCSeahLLFongKSKhooDHThyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves’ disease differ and suggest ophthalmopathy is a multi antigenic diseaseClin Endocrinol (Oxf)20046060060715104563
   PubMed Web of Science ®Google Scholar
• MarinoMLisiSPincheraAIdentification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathyThyroid20011117718511288989
   PubMed Web of Science ®Google Scholar
• MarinòMChiovatoLLisiSRole of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: the hypothesis of Kriss revisitedJ Endocrinol Invest20042723023615164998
   PubMed Web of Science ®Google Scholar
• Kendall-TaylorPAtkinsonSHolcombeMSpecific IgG in Graves’ ophthalmopathy and its relation to retro-orbital and thyroid autoimmunityBMJ1984288118311866424781
   PubMed Web of Science ®Google Scholar
• LahootiHShanmuganathanTChampionBWallJRSerum thyroglobulin levels in patients with thyroid autoimmunity with and without ophthalmopathy or isolated upper eyelid retractionInt Trends Immun201532227
   Google Scholar
• SmithTJTSH-receptor-expressing fibrocytes and thyroid associated ophthalmopathyNat Rev Endocrinol20151117118125560705
   PubMed Web of Science ®Google Scholar
• SmithTJHegedüsLDouglasRSRole of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathyBest Pract Res Clin Endocrinol Metab20122629130222632366
   PubMed Web of Science ®Google Scholar
• FernandoRLuYAtkinsSJMesterTBranhamKSmithTJExpression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter and thyroperoxidase by fibrocytes depends on AIREClin Endocrinol Metab201499E1236E244
   Google Scholar
• FernandoRAtkinsSRaychaudhuriNHuman fibrocytes co-express thyroglobulin and thyrotropin receptorProc Natl Acad Sci U S A20121097427743222517745
   PubMed Web of Science ®Google Scholar
• SmithTJTsaC-CShihM-JUnique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathyThyroid20081898398818788919
   PubMed Web of Science ®Google Scholar
• RotellaCMZonefratiRToccafondiRValenteWAKohnLDAbility of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves’ seraJ Clin Endocrinol Metab1986623573672416769
   PubMed Web of Science ®Google Scholar
• HansenCFraitureBRouhiROttoEFörsterGKahalyGHPLC glycosaminoglycan analysis in patients with Graves’ diseaseClin Sci (Lond)1997925115179176026
   PubMed Web of Science ®Google Scholar
• KahalyGStoverCOttoEBeyerJSchulerMGlycosaminoglycans in thyroid-associated ophthalmopathyAutoimmunity19921381881420810
   PubMed Web of Science ®Google Scholar
• MadedduGCasuARCostanzaCSerum thyroglobulin levels in the diagnosis and follow-up of subacute ‘painful’ thyroiditis. A sequential studyArch Intern Med19851452432473977482
   PubMedGoogle Scholar
• Feldt-RasmussenUBechKDateJThyroid stimulating antibodies, thyroglobulin antibodies and serum proteins during treatment of Graves’ disease with radioiodine or propylthiouracilAllergy1982371611676127965
   PubMed Web of Science ®Google Scholar
• EinhornJFagraeusAJonssonJThyroid antibodies after 131I treatment for hyperthyroidismJ Clin Endo Metab19652512181224
   PubMed Web of Science ®Google Scholar
• BartelenaLMarocciCBogazziFPanicucciMLepriAPincheraAUse of corticosteroids to prevent progression of Graves’ ophthalmopathy after radioiodine therapy for hyperthyroidismN Engl J Med1989321134913522811943
   PubMed Web of Science ®Google Scholar
• MarcocciCBartalenaLBogazziFBruno-BossioGPincheraARelationship between Graves’ ophthalmopathy and type of treatment of Graves’ hyperthyroidismThyroid199221711781525588
   PubMed Web of Science ®Google Scholar
• BoyleITGreigWRThomsonJAWinningJMcGirrEMEffect of thyroid ablation on dysthyroid exophthalmosProc R Soc Med196962119235818232
   PubMedGoogle Scholar
• CatzBPerzikSLTotal thyroidectomy in the management of thyrotoxic and euthyroid Graves’ diseaseAm J Surg19691184344394185884
   PubMed Web of Science ®Google Scholar
• KuriharaHTotal Thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathyThyroid20021226526711952051
   PubMed Web of Science ®Google Scholar
• AntonelliAFerrariSMCorradoAExtra-ocularmuscle cells from patients with Graves’ ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγAutoimmun Rev2014131160116625172242
   PubMed Web of Science ®Google Scholar
• AntonelliARotondiMFerrariSMInterferon-γ-inducible α-chemokine CXCL10 involvement in Graves’ ophthgalmopathy: modulation by peroxisome proliferator-activated receptor-γ agonistsJ Clin Endocrinol Metab20069161462016303841
   PubMed Web of Science ®Google Scholar
• MysliwiecJPalygaIKosciuszkoMKowalskaAGorskaMCirculating CXCL9 and CXCL10 as markers of activity of Graves’ orbitopathy during treatment with corticosteroids and teleradiotherapyHorm Metab Res2012441395796122752955
   PubMed Web of Science ®Google Scholar
• LahootiHCultroneDEdirimanneSAssociation of the CASQ1 gene rs3838216 with Graves’ ophthalmopathy and Hashimoto’s thyroiditis in patients with thyroid autoimmunityOphthalmol Res20142281229
   Google Scholar
• MizokamiTLiAWWallJRStress and thyroid autoimmunityThyroid2004141047105515650357
   PubMed Web of Science ®Google Scholar